Cargando…

Leflunomide: a treatment option for ganciclovir-resistant cytomegalovirus infection after renal transplantation

Cytomegalovirus (CMV) infection after renal transplantation is a problem of increasing concern resulting in significant morbidity and mortality. Widespread use of ganciclovir (GCV) and valganciclovir (VGCV) may cause an increase of CMV resistance to these first line drugs. Other treatment options ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrassy, Joachim, Illner, Wilf Dieter, Rentsch, Markus, Jaeger, Gundula, Jauch, Karl W., Fischereder, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421354/ https://www.ncbi.nlm.nih.gov/pubmed/25949314 http://dx.doi.org/10.1093/ndtplus/sfp004

Ejemplares similares

Use of Leflunomide in Renal Transplant Recipients with Ganciclovir-Resistant/Refractory Cytomegalovirus Infection: A Case Series from the University of Chicago
por: Chon, W. James, et al.
Publicado: (2015)

Ganciclovir-resistant cytomegalovirus infection in renal transplantation
por: Vaz, Raquel, et al.
Publicado: (2014)

Effect of Apheresis for ABO and HLA Desensitization on Anti-Measles Antibody Titers in Renal Transplantation
por: Schönermarck, Ulf, et al.
Publicado: (2011)

Ganciclovir/letermovir: Rebound Cytomegalovirus hepatitis, acquired resistance to ganciclovir and nephrotoxicity: case report
Publicado: (2020)

Successful Treatment with Ganciclovir for Cytomegalovirus Duodenitis following Allogenic Bone Marrow Transplantation
por: Ahn, Jin Hee, et al.
Publicado: (1999)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
por: Vaziri, Siavash, et al.
Publicado: (2014)

Presumed neonatal cytomegalovirus retinitis treated with intravenous ganciclovir
por: Suganya, A, et al.
Publicado: (2020)

Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation
por: Papazian, Laurent, et al.
Publicado: (2021)

Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus
por: Menghi, Viola, et al.
Publicado: (2016)

Molecular Detection and Genotyping of Human Cytomegalovirus in Kidney Transplant Recipients under Ganciclovir Prophylaxis in Iran
por: Behnezhad, Farzane, et al.
Publicado: (2022)

Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis
por: Choopong, Pitipol, et al.
Publicado: (2016)

Ganciclovir penetrates into the cerebrospinal fluid of an infant with congenital cytomegalovirus infection
por: Natale, Fabio, et al.
Publicado: (2015)

Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients
por: Patel, Twisha, et al.
Publicado: (2017)

Risk Factors for Erythrocytosis in Renal Transplantation: Is Ganciclovir Therapy One of Them?
por: Koçak, Fatma Özge Kayhan, et al.
Publicado: (2022)

Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Disease with Different Regimes of Ganciclovir
por: Ahmed, Iftikhar, et al.
Publicado: (2018)

Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Shedding Light on the Elusive Role of Endothelial Cells in Cytomegalovirus Dissemination
por: Sacher, Torsten, et al.
Publicado: (2011)

Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-Generation Sequencing
por: Lodding, Isabelle P, et al.
Publicado: (2021)

Detection of Ganciclovir-Resistant Cytomegalovirus in a Prospective Cohort of Kidney Transplant Recipients Receiving Subtherapeutic Valganciclovir Prophylaxis
por: Wong, Diana D., et al.
Publicado: (2022)

Therapeutic Drug Monitoring of Ganciclovir in Cytomegalovirus-Infected Patients With Solid Organ Transplants and Its Correlation to Efficacy and Toxicity
por: van der Wekken-Pas, Lena C., et al.
Publicado: (2023)

The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein
por: Shannon-Lowe, Claire D, et al.
Publicado: (2010)

Efficacy and safety of topical ganciclovir in the management of cytomegalovirus (CMV)-related anterior uveitis
por: Wong, John X. H., et al.
Publicado: (2016)

Cytomegalovirus-associated esophageal ulcer in an immunocompetent infant: When should ganciclovir be administered?
por: Jang, Hyo-Jeong, et al.
Publicado: (2012)

Therapeutic Drug Monitoring of Ganciclovir Treatment for Cytomegalovirus Infections Among Immunocompromised Children
por: Stockmann, Chris, et al.
Publicado: (2016)

Predictor of Liver Biochemistry Improvement in Patients with Cytomegalovirus Cholestasis after Ganciclovir Treatment
por: Puspita, Gina, et al.
Publicado: (2022)

Leflunomide inhibits the apoptosis of human embryonic lung fibroblasts infected by human cytomegalovirus
por: Qi, Ren, et al.
Publicado: (2013)

Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
por: Khurana, Mark P, et al.
Publicado: (2019)

1584. Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-generation Sequencing
por: Lodding, Isabelle Paula, et al.
Publicado: (2018)

Ganciclovir use evaluation in kidney transplantation departments
por: Mozaffar, Maryam, et al.
Publicado: (2016)

Ganciclovir therapeutic drug monitoring in transplant recipients
por: Märtson, Anne-Grete, et al.
Publicado: (2021)

Fatal lactic acidosis possibly related to ganciclovir therapy in a renal transplant patient?
por: Wittebole, Xavier, et al.
Publicado: (2015)

Cytomegalovirus Retinitis in an ALL Child during Maintenance Therapy Treated Successfully with Intravenous Ganciclovir
por: Celiker, Hande, et al.
Publicado: (2014)

Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir
por: Saraca, Lavinia Maria, et al.
Publicado: (2018)

Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients
por: Qian, Zhuyun, et al.
Publicado: (2018)

Cytomegalovirus Myocarditis Required Extracorporeal Membrane Oxygenation Support Followed by Ganciclovir Treatment in Infant
por: Kim, Bong Jun, et al.
Publicado: (2016)

Effectiveness of Topical Ganciclovir 2% Monotherapy Versus Combined Steroid Therapy in Cytomegalovirus Endotheliitis
por: Kuo, Yu-Wei, et al.
Publicado: (2022)

1753. Neutropenia as a Function of Ganciclovir Exposure During Treatment of Congenital Cytomegalovirus Disease
por: Nishikawa, Javier K, et al.
Publicado: (2023)

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
por: Nakamura, R, et al.
Publicado: (2002)

582. Safety and Efficacy of High-Dose Ganciclovir versus Standard Dosing for Cytomegalovirus Viremia in Solid Organ Transplant (SOT) Recipients
por: Fitzmaurice, Mary Grace, et al.
Publicado: (2020)

Early conversion to a CNI-free immunosuppression with SRL after renal transplantation—Long-term follow-up of a multicenter trial
por: Andrassy, Joachim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n9ksst9qe6blforu0prcp29k62